Clinical Trial

Lower Dialysate Temperature and Post-Dialysis Fatigue

Completed
View on ClinicalTrials.gov →
Summary
The standard dialysate temperature is usually set at 36.5°C in hemodialysis applications. Since this temperature is close to the patient's body temperature, it is ideal for preventing the patient from experiencing hypothermia while ensuring cardiovascular stability. In the literature, it is seen that changing the dialysate temperature, especially cold dialysis applications, is used in the management of nausea, the effect on vital signs, determining hemodialysis adequacy and common complications, and in the management of symptoms such as hypotension, cardiac stability, vascular stability, fatigue, and muscle cramps. However, no study has been found using cold dialysis in the management of fatigue that develops after dialysis.Therefore, the aim of this study is to examine the effect of cold dialysis application on post-dialysis fatigue in patients receiving hemodialysis treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-08; most recent amendment 2026-04-15.
Status change: Active, Not Recruiting → Completed 2026-04-15
Trial Details
NCT Number NCT07071376
Lead Sponsor Baskent University
Conditions Dialysis Related Complication
Enrollment 57 participants
Start Date 2025-05-15
Primary Completion 2025-06-15 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-16